A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

This study has been withdrawn prior to enrollment.

(The 20070201 study was terminated based on evaluation of Palifermin solid tumor data.)

Sponsor:

Collaborator:

Amgen

Information provided by:

Swedish Orphan Biovitrum

ClinicalTrials.gov Identifier:

NCT00540332

First received: October 4, 2007

Last updated: February 27, 2009

Last verified: January 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	September 2008
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)